期刊文献+

帕拉米韦氯化钠注射液治疗儿童流行性感冒的疗效观察 被引量:10

Efficacy of palamivir sodium chloride injection for the treatment of influenza of children
原文传递
导出
摘要 目的探讨帕拉米韦氯化钠注射液治疗儿童流行性感冒的疗效及安全性,为临床安全用药提供依据。方法选取2017年1月-2018年10月涿州市医院收治的流行性感冒患儿240例,按随机数字表法将其分为观察组(n=120)和对照组(n=120)。对照组给予磷酸奥司他韦颗粒口服治疗,观察组给予帕拉米韦氯化钠注射液静脉滴注(10mg/kg,1次/d),观察2组的疗效。结果观察组治疗后的体温恢复正常时间、咳嗽缓解时间、鼻卡他/鼻塞缓解时间、咽喉痛缓解时间及症状完全缓解时间均显著低于对照组,差异有统计学意义(P<0.05)。观察组治疗后的总有效率明显高于对照组(97.5%vs 85.8%,P<0.05)。观察组与对照组治疗后不良反应发生率比较(14.2%vs 9.2%,P>0.05),差异无统计学意义。结论采用帕拉米韦氯化钠治疗儿童流行性感冒的效果较好,能更快地改善发热和流感症状,且不增加不良反应。 Objective To explore the efficacy and safety of palamivir sodium chloride injection for the treatment of influenza in children.Methods A total of 240children with influenza admitted to Zhuozhou Hospital in Hebei province of China from January 2017to October 2018were divided into observation group(n=120)and control group(n=120)based on the random number table method.The control group was treated with oseltamivir phosphate granules,while the observation group was treated with palamivir sodium chloride injection.The efficacy and safety of the two groups were observed.Results The time of normal temperature recovery,cough relief,nasal catarrh/nasal congestion relief,throat pain relief and symptom complete relief in the observation group after treatment were significantly lower than those in the control group(P<0.05).The total effective rate of the observation group after treatment was significantly higher than that of the control group(97.5%vs 85.8%,P<0.05).There was no statistically significant difference in the incidence of adverse reactions after treatment between the two groups(14.2%vs 9.2%,P>0.05).Conclusions Paramivir sodium chloride is a better treatment for childhood influenza to improve fever and flu symptoms more quickly without increasing adverse reactions.
作者 李明 马红超 董冰 杨京敏 LI Ming;MA Hong-chao;DONG Bing;YANG Jing-min(Department of Pediatrics,Zhuozhou City Hospital,Zhuozhou,Hebei 072750,China)
机构地区 涿州市医院儿科
出处 《中国病毒病杂志》 CAS 2020年第2期128-131,共4页 Chinese Journal of Viral Diseases
基金 保定市科学技术研究与发展指导计划项目(17ZF096)。
关键词 帕拉米韦 奥司他韦 儿童 流行性感冒 Palamivir Oseltamivir Children Influenza
  • 相关文献

参考文献8

二级参考文献61

  • 1刘颂,王京燕.抗流感病毒药物的研究进展[J].国外医学(药学分册),2005,32(2):111-115. 被引量:33
  • 2陈祈磊,赵文杰.禽流感及抗禽流感病毒药物[J].中国抗生素杂志,2006,31(10):581-586. 被引量:4
  • 3李兰娟.历史上流感有过几次大规模流行[N].都市快报,2013 -04 -06.
  • 4ISABELLE M,STPHANE P, NEIL SJ, et al. Influenza patho-genesis :Lessons learned from animal studies with H5N1,H1N1Spanish, and pandemic H1N1 2009 influenza [ J ]. Crit CareMed,2010,38 (4s) :e21 -e29.
  • 5樊超.帕拉米韦注射液上市可抗H7N9禽流感[N].亚太日报,2013 -04 -07.
  • 6BABU YS,CHAND P,BANTIA S,et al. BCX-1812( RWJ-270201):Discovery of a novel, highly potent, orally active, and selectiveinfluenza neuraminidase inhibitor through structure-based drugdesign[J]. J Med Chem,2000,43(19) :3482 -3486.
  • 7BEIGEL J,BRAY M. Current and future antiviral therapy of se-vere seasonal and avian influenza[ J]. Antivir Res ,2008 ,78 (1):91 -102.
  • 8GOVORKOVA EA, LENEVA IA, GOLOUBEVA OG, et al.Comparison of efficacies of RWJ-270201,zanamivir, oseltamiviragainst H5N1,H9N2,and other avian influenza viruses[ J]. An-timicrob Agents Chemother, 2001 ,45 (10) :2723 - 2732.
  • 9REECE PA. Neuraminidase inhibitor resistance in influenza viru-ses[J]. J Med Virol, 2007,79(10) : 1577 - 1586.
  • 10Peramivir[ EB/OL]. [2013 -04 -06]. http://www. biocryst.com.

共引文献281

同被引文献71

引证文献10

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部